Professor Robin Christensen is a senior biostatistician: head of ‘Musculoskeletal Statistics Unit’ at the Parker Institute and a professor of biostatistics and clinical epidemiology at the Department of Clinical Research, within the Faculty of Health Sciences at the University of Southern Denmark. He is co-affiliated with the Parker Institute, and the Department of Rheumatology, Odense University Hospital, Denmark.
Professor Christensen did his PhD in evidence-based rheumatology and biostatistics, and works internationally as a statistics (and osteoarthritis) editor for the ’Cochrane Musculoskeletal Group’ (CMSG), as well as being a member of the ’Grading of Recommendations Assessment, Development and Evaluation’ (GRADE) Working Group, the ’Outcome Measures in Rheumatology’ (OMERACT), and was part of the establishment of the ’International Dermatology Outcome Measures’ (IDEOM) initiatives. In the fall of 2017, he was invited to become a founding member of the ‘Technical Advisory Group’ (TAG) in OMERACT; the role of the OMERACT TAG is to critically appraise submitted documentation from various Working Groups. Furthermore, he is a member of the BMJ Open’s statistical advisory board and in 2016 he accepted an invitation to join the team of associate editors for ‘Trials’; a journal which encompasses all aspects of the performance and findings of randomised controlled trials in health; Trials encourages full and transparent reporting of all research (EQUATOR network).
Professor Christensen works with a broad field of biostatistical methods in medical research. This field covers a range of clinical epidemiological problems, where inference from meta-epidemiology, study designs, decision making processes, statistical analysis plans, use and misuse of statistics, and transparency dominate. He has a passion for meaningful, accurate studies that address “answerable questions”, owing a great debt of gratitude to a long history of distinguished founding fathers of clinical epidemiology, who highlighted the need for strengthening the empirical practice of medicine and proposed initial evidentiary rules for guiding clinical decisions. Stressing the importance of classical statistical methods (incl. transparent reporting of these), he is responsible for the development and analysis of numerous clinical trials and projects, both within and outside of the Parker Institute and the Department of Rheumatology, Odense University Hospital, Denmark.
Professor Christensen is a strong advocate of the REWARD (REduce research Waste And Reward Diligence) Campaign; i.e., focus on how to increase value and reduce waste in biomedical research. Professor Christensen promotes these principles by being a “Lean Thinker”; the core idea is to maximize customer (e.g. patient) value while minimizing waste.
Professor Christensen has published more than 250 peer reviewed articles, including articles in the Lancet, CMAJ, Annals of Internal Medicine, BMJ and JAMA.